Share Name Share Symbol Market Type Share ISIN Share Description
Summit Corporation LSE:SUMM London Ordinary Share GB00BN40HZ01 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 202.50p 195.00p 210.00p 202.50p 202.50p 202.50p 249.00 07:36:14
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 1.4 -20.1 -28.8 - 124.51

Summit Corp Share Discussion Threads

Showing 38326 to 38350 of 38350 messages
Chat Pages: 1534  1533  1532  1531  1530  1529  1528  1527  1526  1525  1524  1523  Older
DateSubjectAuthorDiscuss
23/3/2017
21:14
Just out on twitter We're hiring! View open positions & find out more about joining our team advancing txs in #Duchenne & #Cdiff hTTp://www.summitplc.com/about/careers/ hTTp://www.summitplc.com/about/careers/ Shows Summit on the move again reflects Glyn's earlier positive presentation.
chrisatrdg
23/3/2017
08:40
I think we ticked it up, vatnabrekk :-)
solomon
23/3/2017
08:29
Good to hear they have term sheets on the table re RDZ and whichever route they go, confirmed it will be non dilutive.
waterloo01
22/3/2017
23:36
Summit Therapeutics plc (SMMT) Charges Ahead 10.41%, Just After Opening Bell on March 22 to Bolster Health Care Stocks http://www.financialpress.com/2017/03/22/summit-therapeutics-plc-smmt-charges-ahead-10-41-just-after-opening-bell-on-march-22-to-bolster-health-care-stocks/
football
22/3/2017
23:06
Hope it doesn't go too high until I get my top-up in the morning!
vatnabrekk
22/3/2017
18:44
This evening sounded positive to me & we may get some news on C-Diff this summer if they can agree a non partnership deal with Government type funding. Edit: Based on NASDAQ close some people must also have thought there were some upbeat comments today - close $12.95 at 1.25 $ to £ = £2.07. In addition high level of transactions - looking good maybe some upturn on AIM Thursday.
chrisatrdg
22/3/2017
14:19
Tree shaking?
hugus maximus
22/3/2017
14:06
High volume in US. Reached the average daily trading volume (3 month average I reckon)in the first half hour.
solomon
22/3/2017
13:43
Well not at $13.6 in the US now
football
22/3/2017
13:39
We're suffering from what seems to be a general market wobble both here and in the USA re: Trump.
hugus maximus
21/3/2017
11:16
Quick question of topic anyone here know or have anything to do with MELAS ie. a new research/testing that's happening as the Internet is pretty threadbare of anything to do with it tia
football
20/3/2017
22:03
Thanks football for your post. I found recording of Glyn very interesting & a better understanding of why we are where we are with C-Diff. Good introduction for new investors. Edit: Registration for Wednesday set up per link below: hTTp://www.summitplc.com/investors/presentations/
chrisatrdg
20/3/2017
20:38
Boardroom Talk: Summit Therapeutics' long road to drug approval Summit Therapeutics(SUMM) is a small-cap biotech company with two drugs in clinical trials at either end of the new drugs space: a low risk, lower reward antibiotic and a high risk, higher reward Duchenne Muscular Dystrophy cure. Does this make it an ideal biotech investment? Megan Boxall investigates. http://www.investorschronicle.co.uk/2017/03/20/shares/news-and-analysis/boardroom-talk-summit-therapeutics-long-road-to-drug-approval-XDHwSegtbATP0GU0Aas8AM/article.html anyone subscrbe here?
football
20/3/2017
09:38
Re: NASDAQ - in addition our AIM share price at 207p is much the same as NASDAQ close ... so no reason for an share price hike here.
hugus maximus
20/3/2017
09:32
Thanks Waterloo, that's what I remember reading too and I wonder if timing has been made specific as to when first dose of F6 is /was administered? With the absorption being so vastly improved in F6, am hoping the market is aware that so long as some small "principle" is detectable in F3 trials, F6 results should then follow on with vastly enhanced improvement. i.e. It would surely be a smart move if some "F6 first patients dosed" RNS is made explaining all this. I wonder if the first dosing of F6 has happened yet?
hugus maximus
20/3/2017
08:53
I really would take care with the Nasdaq closing price as it was marked up on very low volume on the last trade. Re F6 dosing I seem to remember, but happy to be corrected, that they are dosing both F3 and F6 at the same time, although F3 was started earlier and with more kids, so F3 likely to make up the majority of the initial results.
waterloo01
17/3/2017
22:19
pick up where we left off Monday with the charts..onwards and upwards then..gla lth's
abergele
17/3/2017
21:05
Summit Therapeutics PLC (ADR) NASDAQ: SMMT - Mar 17, 4:00 PM EDT 13.21USDPrice increase1.11 (9.17%)
football
17/3/2017
09:15
Does anyone have an ETA re: F6 dosing and initial results? I know we're due to hear of progress with F3 Q2/3 but I've been wondering how soon that might happen with F6?
hugus maximus
17/3/2017
09:13
Indeed the Marathon/PTC scenario is a total scandal .. how on earth can a company act so shamelessly?
hugus maximus
16/3/2017
17:15
hTtps://endpts.com/after-failing-to-win-over-the-fda-for-its-own-drug-ptc-buys-a-controversial-duchenne-md-therapy-from-marathon/ Rightly being slatted especially for calling it disease modifying, which it is not. Welcome to the new world of alternative truth.
waterloo01
15/3/2017
11:02
Rns Summit Therapeutics plc Summit Therapeutics To Present At The Oppenheimer 27th Annual Healthcare Conference Oxford, UK, 15 March 2017- Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and Clostridium difficile infection, announces that Mr Glyn Edwards, Chief Executive Officer, will present at the Oppenheimer 27(th) Annual Healthcare Conference, 22 March 2017 at 2:10pm EDT in New York City. A live audio webcast of the presentation will be available through the Investors section on the Company's website, www.summitplc.com. A replay of the webcast will be available soon after the live presentation http://uk.advfn.com/stock-market/london/summit-corp-SUMM/share-news/Summit-Therapeutics-plc-Summit-Therapeutics-To-Pre/74098359
football
14/3/2017
19:48
It's made a good effort today though H.M. The charts showing any investor where we're heading,past all dma's onwards and upwards. looking at the yanks side,a few cents rise on their T trades and they have to sell by the looks of things....gla
abergele
13/3/2017
14:53
Did expect a bit of movement today after weekend posts
football
11/3/2017
18:01
Great stuff... timing couldn't be better ... finger's crossed for a new golden period in american pharmaceuticals. GLA
hugus maximus
Chat Pages: 1534  1533  1532  1531  1530  1529  1528  1527  1526  1525  1524  1523  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V: D:20170324 11:57:46